AUPH - Aurinia gains on Lupkynis label update
2024-04-30 08:42:34 ET
More on Aurinia Pharma
- Aurinia Pharmaceuticals: Potential For Significant Upside By Year-End 2024
- Aurinia Pharma: Cheaper Now, But Buyout Hopes Dashed
- Aurinia Pharmaceuticals 2023 Earnings Review: Calling 'Time' In Last Chance Saloon
- Aurinia drops after Q4 miss; strategic review fails
- Aurinia Pharma GAAP EPS of -$0.19 misses by $0.03, revenue of $45.1M misses by $0.06M